Graduate School of Education, Nagasaki University, Nagasaki, Japan; Center for Health and Community Medicine, Nagasaki University, Nagasaki, Japan.
Center for Health and Community Medicine, Nagasaki University, Nagasaki, Japan.
J Affect Disord. 2019 Feb 15;245:364-370. doi: 10.1016/j.jad.2018.11.039. Epub 2018 Nov 6.
This study assessed whether a combined intervention of omega-3 polyunsaturated fatty acids (PUFAs) and psychoeducation better improved mild to moderate depression in workers compared to psychoeducation alone.
This study was a double-blinded, parallel group, randomized controlled trial that compared the intervention group, receiving omega-3 fatty acids, with a control group, receiving a placebo supplement. Participants receiving omega-3 fatty acids took 15 × 300 mg capsules per day for 12 weeks. The total daily dose of omega-3 PUFAs was 500 mg docosahexaenoic acid and 1000 mg eicosapentaenoic acid (EPA). The Beck Depression Inventory®-II (BDI-II) was used to assess the severity of depression after treatment.
After 12 weeks of treatment, BDI-II scores were significantly lower in the placebo and omega-3 group, when compared to their respective baseline scores (Placebo: t = - 4.6, p < 0.01; Omega-3: t = - 7.3, p < 0.01). However, after 12 weeks of treatment, we found no significant difference between both groups with respect to changes in the BDI-II scores (0.7; 95% CI, - 0.7 to 2.1; p = 0.30).
This study did not measure blood omega-3 fatty acid concentration and presented a high-dropout rate. Moreover, our results may not be generalizable to other regions.
The results show that a combination of omega-3 fatty acids and psychoeducation and psychoeducation alone can contribute to an improvement in symptoms in people with mild to moderate depression. However, there is no difference between the interventions in ameliorating symptoms of depression.
本研究评估了与单纯心理教育相比,ω-3 多不饱和脂肪酸(PUFAs)与心理教育相结合的干预措施是否能更好地改善轻度至中度抑郁的工人。
这是一项双盲、平行组、随机对照试验,比较了干预组(服用ω-3 脂肪酸)和对照组(服用安慰剂补充剂)。服用ω-3 脂肪酸的参与者每天服用 15×300mg 胶囊,持续 12 周。ω-3 PUFAs 的总日剂量为 500mg 二十二碳六烯酸和 1000mg 二十碳五烯酸(EPA)。采用贝克抑郁量表第二版(BDI-II)评估治疗后抑郁的严重程度。
治疗 12 周后,安慰剂组和ω-3 组的 BDI-II 评分均明显低于各自的基线评分(安慰剂:t=-4.6,p<0.01;ω-3:t=-7.3,p<0.01)。然而,治疗 12 周后,两组之间 BDI-II 评分的变化无显著差异(0.7;95%CI,-0.7 至 2.1;p=0.30)。
本研究未测量血液中ω-3 脂肪酸的浓度,且脱落率较高。此外,我们的结果可能不适用于其他地区。
结果表明,ω-3 脂肪酸与心理教育相结合以及单纯的心理教育都可以改善轻度至中度抑郁人群的症状。然而,两种干预措施在改善抑郁症状方面没有差异。